SOLICITATION NOTICE
B -- Development of reference methods and materials for assessing human exposure to microcystin and related toxins.
- Notice Date
- 6/14/2014
- Notice Type
- Presolicitation
- NAICS
- 541990
— All Other Professional, Scientific, and Technical Services
- Contracting Office
- Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- 2014-N-16594
- Archive Date
- 6/30/2014
- Point of Contact
- Linda F. Williams, Phone: 770-488-2692, Tayaria L Smith, Phone: 7704882797
- E-Mail Address
-
luw9@cdc.gov, gqq4@cdc.gov
(luw9@cdc.gov, gqq4@cdc.gov)
- Small Business Set-Aside
- N/A
- Description
- The Centers for Disease Control and Prevention (CDC), National Center for Environmental Health (NCEH), Division of Laboratory Sciences (DLS), Emergency Response Branch (ERB), intends to negotiate a sole source contract with The University of Melbourne, Bio21 Molecular Science and Biotechnology Institute, Laboratory of Biological and Biomedical Mass Spectrometry, Parkville, Victoria, Australia, to develop reference methods and materials specific for assessing exposure to microcystin and related toxins. The Laboratory of Biological and Biomedical Mass Spectrometry of The University of Melbourne is an international leader in biological and biomedical mass spectrometry and have ultra high-performance liquid chromatography-tandem mass spectrometry UHPLC-MS and UHPLC-high resolution mass spectrometry capabilities. The result of this requirement will be incorporated in the methodology used within the CDC/NCEH/DLS/ERB Method Development Laboratory for the assessment of human exposure to freshwater toxins currently unaddressed by CDC emergency response methods. The laboratory is a leader in quantitative proteomics and has a demonstrated track record of developing quantitative analytical methods. This laboratory's ability ensures that the reference methods and materials can be tested prior to transfer to the CDC. The laboratory is a leader in phosphopeptide analysis and will be able to incorporate analyses of the toxin peptides similarly to the CDC's unique peptide analysis methods for organophosphorus adducts to serum butyrylcholinesterase. The laboratory's unique location was also considered as it is in the recognized center of knowledge for marine toxin research and natural abundance. The Laboratory of Biological and Biomedical Mass Spectrometry of The University of Melbourne is the only resource that satisfies all of the requirements for CDC. The use of other than full and open competition for this acquisition is conducted under the authority of 41 United States Code (U.S.C.) 253(c)(1) as set forth in Federal Acquisition Regulations, Subpart 6.302-1, Only one responsible source and no other supplies or services will satisfy agency requirements. This notice of intent is not a request for competitive proposals. A determination to compete this procurement based on a response to this notice is solely within the discretion of the Government. Interested parties who believe they possess the capabilities to satisfy this requirement should submit a Capability Statement demonstrating their abilities to meet this requirement. All responses will be considered. All Capability Statements shall be received by the closing date of this synopsis and shall be submitted in writing. Responses may be sent via email to luw9@cdc.gov. No solicitation will be issued. No telephone inquiries will be accepted.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/2014-N-16594/listing.html)
- Place of Performance
- Address: Parkville, Victoria, Australia 3052, Australia
- Record
- SN03395614-W 20140616/140614233029-ec5ce259e5f10de376e28a9672657c7b (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |